Overview
- The five-year joint lab will use Nvidia’s newest Vera Rubin AI chips and builds on Lilly’s recent Grace Blackwell supercomputer project.
- Teams from both companies plan to co-locate and begin work by late March, with the Bay Area site to be named in March.
- Beyond discovery, the partners will explore applications of accelerated computing across Lilly’s manufacturing and commercial operations.
- Nvidia released new AI models alongside the announcement, including an update that checks whether proposed drugs are practical to synthesize.
- The companies did not say whether Nvidia’s funds could flow to Lilly and be used to buy Nvidia chips, a detail that has drawn scrutiny.